A Caregiver-Assisted Rehabilitation With Strategy Training (CAR-ST) for Stroke Patients

ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTaipei Medical University

About this trial

The goal of this randomized controlled trial is to examine if involving the caregivers in the strategy training (i.e. caregiver-assisted rehabilitation with strategy training, CAR-ST) works to improve activity functions in community-dwelling adults after stroke. The main questions it aims to answer are:

Does CAR-ST and strategy training alone lead to greater improvements in activity performance among stroke survivors relative to the control intervention with education? Does CAR-ST outperform strategy training alone in the efficacy of activity outcomes? Do the activity effects of CAR-ST transfer to the impairment and participation domains of outcomes?

Researchers will compare the efficacy of the CAR-ST intervention against strategy training alone or control intervention (education program) to see if caregivers contribute to post-stroke functional improvements.

Participants will:

* receive CAR-ST, strategy training only, or an education program 1 to 2 sessions per week until finishing 10 sessions. * be assessed clinical outcomes at 4 times: pre-intervention, post-intervention, 3-month, and 6-month follow-up.

Eligibility criteria

Qualifiers

Being willing to provide informed consent

Diagnosis with ischemic and/or hemorrhagic stroke

Modified Rankin Scale (mRS) ranges from 2 to 4

Rehabilitation frequency less than 3 days per week

Disqualifiers

Undergoing palliative care

Major diseases or severe conditions influencing study participation, such as global aphasia, dementia, multiple organ failure, immobilization due to fracture, etc

Moderate post-stroke cognitive impairment, with Montreal Cognitive Assessment score <22

Pre-stroke mRS > 1

Trial design

Treatments tested in this trial

  • Caregiver-Assisted Rehabilitation with Strategy Training
  • Strategy Training
  • Education

Treatment groups

261 Participants
are divided into 3 treatment groups

Sponsors and collaborators